Licogliflozin
Product Specifications
UNSPSC Description
Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
Target Antigen
SGLT
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Licogliflozin.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic)|H2O : 2 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@H](C2=CC(CC3=CC=C4C(OCCO4)=C3)=C(CC)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Molecular Weight
416.46
References & Citations
[1]Monica A. Konerman, et al. Overview of Clinical Treatment Trials for NASH.Curr Hepatol Rep. 2017 Dec;16(4): 366-373.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-109092/Licogliflozin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-109092/Licogliflozin-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1291094-73-9
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Geobacter lovleyi Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial
Recombinant Geobacter lovleyi Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial
